$HHSE BLOG: Good Business Math: How to turn $4-mm in

New Post Public Reply Private Reply Replies (0) Message Board
HHSErocks SmallCapTraders #142951
108
$HHSE BLOG: Good Business Math: How to turn $4-mm in Private Investment & Presales into a $100-MM Revenue Stream


Friday, September 15, 2023

(Click on link to view photos)


http://hannoverhousemovies.blogspot.com/2023/...mm-in.html



Greetings HHSE Friends & Followers - We cannot stress how material and monumental the news of today is: that we are going to be the FIRST production company to make a fully CGI - Artifical Intelligence generated animated feature with JOURNEY TO UTOPIA .

For decades, Disney, Pixar, Fox and Universal / Amblin have controlled the $400+BILLION annual world animation market - due to the obstacles of the HUGE production costs and multi-year schedules that animated features have traditionally required. That all goes away with the advent of Ultra-HD quality AI generated animation, following top-shelf character designs, scene structures and built atop a solid script with Academy Award level voice actors.

Suddenly, a (currently) small company like Hannover House (and our new INTELIMATION AI division) can produce a film that looks and feels comparable to the top studio releases.

But we can do it for $4-million and finish it in less than 8-months. Best of all, the production costs are fully covered by production incentives, bank gap credit and private investors... so HHSE does not have to struggle to find capital or dilute the company's share structure with stock issuances.

This is a seminal moment in the company, and one that will be further enhanced by our uplist filings and the MyFlix division.



Get ready, friends. It's going to be an exciting ride!




Hannover House forms InteliMation AI for first major A.I. Animated Feature Production



JOURNEY TO UTOPIA to begin production in December with A-List Voice & Music Talent

Major launch planned for Cannes and Summer (2024) Theatrical Release



New York, NY - InteliMation AI, a newly formed division of indie studio Hannover House, Inc. (OTC: HHSE), has secured a private investment commitment to produce the world’s first fully A.I. and CGI generated feature film, the family appeal fantasy film, “ Journey to Utopia.” Featuring a voice talent cast of Academy Award winning actors and box office stars , the film’s visuals will be fully generated using cutting-edge Artificial Intelligence visual rendering, based on producer-supplied scene structure input and character designs.



“We have been trying to produce this film for the past ten years,”
said Eric Parkinson, C.E.O. of Hannover House. “But the visual demands of creating the land of Utopia made the production costs prohibitive and financially risky. That has changed now with the new A.I. technology and our improved strategy to make the film animated as opposed to live-action,” he concluded.



“The Artificial Intelligence CGI technology has reached a point where we can create an animated feature that is visually comparable to a $200-million-dollar studio production, but completed for a fraction of the cost and time,” said Parkinson. “From script to theatrical DCP, we can produce a major studio quality animated feature in less than eight months.”



“The technology from InteliMation should herald in a major paradigm shift in entertainment,” said Christian Large, an independent producer and advisor to Hannover House. “High-end animated features will no longer take multiple years and hundreds-of-millions of dollars to produce. This technological breakthrough will enable a broader range of stories to be created and released, which ultimately will help expand the market, ” he concluded.



The script for “ JOURNEY TO UTOPIA ” was written by Mike Snyder (“Wildfire”) based on a story by Eric Parkinson. The production is in negotiations to secure three Academy Award winning actors as voice talent for the film. Shirley MacLaine is pegged for the role of “Mother Goose;” Forest Whitaker is being pursued to portray the principal antagonist, “Valkerna,” and Kim Basinger is being pursued in the role of “Connie Hammonds,” the mother of one of the kids who becomes trapped in the land of Utopia.



Pending receipt of a Screen Actors Guild waiver for the production, recording of voice talent is expected to start in late November. A promo reel is planned for the Cannes 2024 festival with a USA Theatrical launch targeted for July 2024.

The world animation market will generate over $411-billion dollars in 2023 , according to Statista Research Department – and is expected to grow to over $580-billion by the year 2030. The A.I. fueled software technology pioneered by Hannover House and InteliMation will revolutionize how animated features and television programming are made.



Hannover House and InteliMation are targeting to complete two animated features in 2024, with three set for 2025 and four features per year beginning in 2026. Hannover House will handle the sales representation of the films worldwide, and will coordinate North American theatrical and ancillary sales campaigns with exhibitors, partner studios and major video-on-demand platforms. Hannover House was formed in 1993 and has found success in a variety of indie film distribution arenas, from DVD and VOD distribution to theatrical exhibition.



The release plans for “Journey To Utopia” will follow a traditional model of a wide USA theatrical launch, followed by Video-On-Demand and physical goods (DVDs / BluRay units).



About Eric Parkinson and Hannover House

Eric Parkinson is an indie film distribution veteran of over thirty-five years, best known for his long reigns as CEO of both Hannover House, Inc. and Hemdale Communications. Parkinson has been directly involved with the release of more than 1,500 feature titles, including notable release campaigns for commercial hits including “Terminator,” “Highlander 2” and Best Picture Oscar winners “Platoon” and “The Last Emperor.” Animated features distributed by Parkinson include three #1 Billboard Magazine Top Selling hits, “Little Nemo: Adventures in Slumberland”, “The Magic Voyage” and “The Princess and the Goblin.” On the production side, Parkinson has over fifty feature film credits as a Producer or Executive Producer, and just completed his directorial debut with “WILDFIRE: The Legend of the Cherokee Ghost Horse,” starring Anne Heche in her final feature release. Hannover House was formed in 1993 as a book publisher, but grew into a top ten Walmart DVD supplier by the mid ‘2000’s with dozens of indie releases populating the popular DVD Budget Bins nationwide. The company expanded into theatrical releases, which were a transitional business model to service the growing Video-On-Demand market. Hannover House stopped representing third-party / indie films in 2018 in favor of a business model that focuses resources on the creation of original, high-profile feature productions.



For More Information Contact:

ERIC PARKINSON, Hannover Studios AI, Eric@HannoverHouse.com / 818-481-5277
Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

BioXcel Therapeutics Faces Challenges Amidst 52-Week Low

Updated Category News Views 85

BioXcel Therapeutics: Facing the Heat BioXcel Therapeutics Inc. (BTAI) is in the doghouse—its stock just hit a jaw-dropping 52-week low of $0.53. That's an eye-watering drop of over 80% in the last year. Investors are glued to their screens, weighing whether to grab some shares at rock-bottom prices or steer clear as BioXcel grapples with mounting obstacles. This sharp...

Continue Reading
Guidehouse Welcomes Ron White as New Chief Information Officer

Updated Category News Views 315

Guidehouse Appoints Ron White as Chief Information Officer Advancing the firm's AI-led strategy with visionary leadership to drive business transformation and scalable innovation MCLEAN, Va. – Guidehouse, a global AI-led professional services firm, has recently appointed Ron White as its Chief Information Officer (CIO). With over 35 years of expertise in enterprise...

Continue Reading
Natural Ingredients Driving Growth in Cosmetics Market

Updated Category News Views 186

Market Growth Driven by Consumer Demand Recent studies indicate that the chemicals market for cosmetics and toiletries is experiencing significant growth. The market is set to increase from $27.7 billion to an impressive $35 billion by the end of 2029. This momentum speaks volumes about the trends affecting consumer preferences and the investment patterns of leading...

Continue Reading
Securities Investigation Alert for Semler Scientific Investors

Updated Category News Views 118

Understanding the Semler Scientific Investigation The Rosen Law Firm is actively investigating potential securities claims for investors of Semler Scientific, Inc. (NASDAQ: SMLR). This initiative addresses concerns regarding the possibility that the company may have provided significantly misleading information about its business practices to the public. Why You Should Be...

Continue Reading
Exciting Updates from Bitget Wallet: Join Fomo Thursdays

Updated Category News Views 390

Bitget Wallet Introduces Fomo Thursdays Events Bitget Wallet, a prominent non-custodial crypto wallet, is thrilled to announce the launch of its fourth Fomo Thursdays event, brought to life in collaboration with Velo Protocol. This event focuses on broadening participation in the crypto space, featuring a staggering prize pool of 3.47 million VELO tokens and 50,000 slots...

Continue Reading